The First Impact Factor of the European Journal of Therapeutics


Abstract views: 257 / PDF downloads: 203

Authors

DOI:

https://doi.org/10.58600/eurjther1687

Keywords:

Journal Citation Reports, journal impact factor, Emerging Sources Citation Index

Abstract

Dear Colleagues,

The statement made by Journal Citation Reports on 26 July 2022, it was reported that some important updates in the journal metrics will be published in 2023 [1]. The most striking of these changes was that the journal impact factor would now be calculated, including journals from the Arts and Humanities Citation Index (AHCI) and the Emerging Sources Citation Index (ESCI).

On 28 June 2023, the current metrics of the journals indexed in the Web of Science were shared by the Journal Citation Reports for 2022 [2]. As it is known, the European Journal of Therapeutics is indexed in the ESCI and is included in the Category of Medicine, General & Internal. Therefore, the impact factor was calculated for the European Journal of Therapeutics for the first time.

According to the report recently announced by Journal Citation Reports, the impact factor of the European Journal of Therapeutics for 2022 is 0.3 (Fig. 1) [3]. In addition, the European Journal of Therapeutics ranks ninetieth among one hundred fifty-seven (90/157) in the Category of Medicine, General & Internal, and ESCI-indexed journals [4].

Although the first impact factor declared for the European Journal of Therapeutics is 0.3 is not a bad value, it is an inevitable reality that it should be better. On the other hand, in previous editorials [5, 6], it was reported that the articles accepted in the European Journal of Therapeutics were now published as Accepted / Early Views Articles quickly [6]. In addition, it was stated that the editorial team was enriched with many internationally important academicians in their fields [5]. Moreover, there will be various revisions and improvements planned to be made to the journal's publication policy in the near future.

We think these improvements may play an essential role in increasing the impact factor of the European Journal of Therapeutics in the long term.

Yours sincerely

Metrics

Metrics Loading ...

References

Announcing changes to the 2023 Journal Citation Reports. https://clarivate.com/blog/clarivate-announces-changes-to-the-2023-journal-citation-reports-release/ Accessed Date 05 July 2023

Unveiling the Journal Citation Reports 2023: Supporting research integrity with trusted tools and data. https://clarivate.com/blog/unveiling-the-journal-citation-reports-2023-supporting-research-integrity-with-trusted-tools-and-data/ Accessed Date 05 July 2023

European Journal of Therapeutics's profile in the Journal Citation Reports. https://jcr.clarivate.com/jcr-jp/journal-profile?journal=EUR%20J%20THER&year=2022&fromPage=%2Fjcr%2Fhome Accessed Date 05 July 2023

Category of Medicine, General & Internal, and ESCI-indexed journals. https://jcr.clarivate.com/jcr/browse-journals Accessed Date 05 July 2023

Balat A, Eren ŞH, Menzilcioğlu MS, et al. (2023) News from the European Journal of Therapeutics: A new issue and a new editorial board. Eur J Ther 29:e2-e9. https://doi.org/10.58600/eurjther.20232902-edit2.y

Balat A, Eren ŞH, Menzilcioğlu MS, Bahşi İ (2023) Editorial: From the Incoming Editors of the European Journal of Therapeutics (Eur J Ther). Eur J Ther 29:e1-e1. https://doi.org/10.58600/eurjther.20232902-edit1.y

Downloads

Published

2023-07-07

How to Cite

Balat, A., Eren, Şevki H., Menzilcioğlu, M. S., & Bahşi, İlhan. (2023). The First Impact Factor of the European Journal of Therapeutics. European Journal of Therapeutics, e10-e11. https://doi.org/10.58600/eurjther1687

Issue

Section

Editorial